CorMedix (CRMD) Tops Q2 EPS by 12c, Beats on Revenue
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q2 EPS of $0.28, $0.12 better than the analyst estimate of $0.16. Revenue for the quarter came in at $39.7 million versus the consensus estimate of $33.06 million.
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
